US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist

3.330
+0.130+4.06%

Close Nov 25 16:00 ET

3.350
+0.020+0.60%

Post 20:01 ET

436.77MMarket Cap-1616P/E (TTM)

Prime Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Prime Medicine Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 3.750M	--
--	2024/Q4	-- / 287.500K	--
--	2024/Q3	0.000 / 7.118M	--
--	2024/Q2	0.000 / 1.358M	--
--	2024/Q1	591.000K / 912.500K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 3.750M--

--2024/Q4-- / 287.500K--

--2024/Q30.000 / 7.118M--

--2024/Q20.000 / 1.358M--

--2024/Q1591.000K / 912.500K--

Unlock Free Earnings Estimates

Open Account

Prime Medicine Earnings Reports

Prime Medicine | 8-K: Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 12 16:55 ET

Prime Medicine | 10-Q: Q3 2024 Earnings Report

Nov 12 16:16 ET

Prime Medicine | 10-Q: Q2 2024 Earnings Report

Aug 8 08:29 ET

Prime Medicine | 8-K: Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates

Aug 8 08:14 ET

Analyst Rating

Updated: Nov 13, 2024

Buy

Buy
71.43%
Hold
28.57%
Sell
0.00%

Price Target

No Data

Heat List

Overall